Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors	Arterial Occlusive Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder	Recruiting	Phase 4	2026-02-05		NCT06691191

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Florida	315

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Florida Jacksonville	Jacksonville	United States	12

Clinical trials